This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Loyalty Strained at Caremark

Caremark's (CMX) relationships with many of its biggest customers are looking increasingly unhealthy.

The giant pharmacy-benefit manager, or PBM, faces a new probe in the state of Illinois, the Chicago Tribune recently reported. The company is suspected of illegally selling Illinois customers prescription drugs that were returned through the mail and never tested for possible damage. It has also irked Illinois lawmakers by failing to disclose terms of its big state contract.

Caremark faces ongoing problems in Florida as well. There, two former Caremark pharmacists have accused the company of defrauding and endangering state customers. The federal government -- a major Caremark customer -- has expressed interest in that case.

In addition, Caremark faces a broader probe involving attorneys general from 23 states and the District of Columbia. Caremark has yet to identify every state participating in the investigation, but a similar probe targeting Medco (MHS) attracted several big states -- including California -- that conduct business with the PBM. Caremark serves as the PBM for the California Public Employees' Retirement System, or Calpers, a giant organization known for its shareholder activism.

For Caremark, the government contracts are significant. The Illinois contract, which Caremark is currently trying to renew, is valued at more than $200 million a year. The Florida contract is worth about $150 million a year. And the deal with Calpers brings in an estimated $250 million annually.

Still, the federal contract ranks as a far bigger prize. It is expected to generate more than $1.5 billion in revenue this year.

Medco lost the huge contract to Caremark last year after federal prosecutors began investigating Medco's own business practices. But Patrick Burns, a spokesman for the nonprofit Taxpayers Against Fraud, says the federal government may have "jumped out of the kettle and into the fire" when it chose Caremark as its replacement PBM. Going forward, he believes that Caremark -- like Medco -- could lose some government business as a result of the mounting scrutiny.
1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
MHS $70.30 0.00%
ESRX $73.73 0.00%
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs